Dr. Adenrele Olajide, M.D.07 Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 |
Charles Stein, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 |
Leslie Jane Crofford, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 |
Elizabeth T Lyons, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 501, Nashville, TN 37205 Phone: 629-255-2126 Fax: 629-255-4117 |
Leslie A Cuevas, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 4230 Harding Pike, Suite 301, Nashville, TN 37205 Phone: 615-297-2700 Fax: 615-386-2399 |
Dr. Narender Annapureddy, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1161 21st Ave S, Suite T3113, Nashville, TN 37232 Phone: 615-322-1900 |
Dr. Glenn C Douglas, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 |
Kevin Wayne Byram, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 |
Robert Deaver Collins Jr., M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2001 Charlotte Ave, Suite 102, Nashville, TN 37203 Phone: 615-321-3277 Fax: 615-321-3166 |
Hillary Kaplan, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 |
Poonam Ramesh Somai, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Road, Suite 400, Nashville, TN 37205 Phone: 615-297-2700 Fax: 615-386-2399 |
Victor M Byrd, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 222 22nd Ave N, Nashville, TN 37203 Phone: 629-255-2183 Fax: 629-255-4062 |
Gary R Margolies, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 300 20th Ave N, 9th Floor, Nashville, TN 37203 Phone: 615-284-1400 Fax: 615-284-1693 |
Christian J Rhea, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 222 22nd Ave N, Nashville, TN 37203 Phone: 629-255-2184 Fax: 629-255-4063 |
News Archive
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses - and as pharmaceutical companies develop new drugs that otherwise could only be administered by injecting into the eye with a hypodermic needle.
More than 10 per cent of weightlifters, in a study conducted by Southern Cross University in northern NSW, believe that they are too small, and may suffer from a psychological disorder known as muscle dysmorphia. Tthe psychological condition has been nicknamed as "reverse anorexia" or "manorexia." and is usually characterized by sufferers being determined to become more muscular, despite some exhibiting more muscles than the average person.
High-volume lung transplant centers have lower transplantation costs and their patients are less likely to be readmitted within 30 days of leaving the hospital following surgery, according to a new study of more than 3,000 Medicare patients who received lung transplants.
A Washington Post editorial examines the future of PEPFAR under the Obama administration, as outlined in a five-year strategy released earlier this month. Though "[m]any organizations, including Doctors Without Borders, continue to worry that Mr. Obama is 'flat-lining' funding for the vital program," this "ignores Mr. Obama's move to make PEPFAR the center of a larger $63 billion global health initiative to develop more comprehensive and integrated approaches to care," the editorial writes.
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel or generic controlled release and targeted release oral solid dosage drugs, today announced that the staff of the Nasdaq Stock Market has granted the Company an extension of the deadline to regain compliance with Nasdaq Listing Rule 5550(b).
› Verified 2 days ago